Smith R - Search Results

1

Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.

Qu CF, Song EY, Li Y, Rizvi SM, Raja C, Smith R, Morgenstern A, Apostolidis C, Allen BJ. Qu CF, et al. Among authors: smith r. Clin Exp Metastasis. 2005;22(7):575-86. doi: 10.1007/s10585-005-5788-9. Epub 2006 Feb 11. Clin Exp Metastasis. 2005. PMID: 16475028

2

In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595.

Qu CF, Songl YJ, Rizvi SM, Li Y, Smith R, Perkins AC, Morgenstern A, Brechbiel M, Allen BJ. Qu CF, et al. Among authors: smith r. Cancer Biol Ther. 2005 Aug;4(8):848-53. doi: 10.4161/cbt.4.8.1892. Cancer Biol Ther. 2005. PMID: 16082185 Free article.

3

MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.

Qu CF, Li Y, Song YJ, Rizvi SM, Raja C, Zhang D, Samra J, Smith R, Perkins AC, Apostolidis C, Allen BJ. Qu CF, et al. Among authors: smith r. Br J Cancer. 2004 Dec 13;91(12):2086-93. doi: 10.1038/sj.bjc.6602232. Br J Cancer. 2004. PMID: 15599383 Free PMC article.

4

Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.

Nielsen A, Scarlett CJ, Samra JS, Gill A, Li Y, Allen BJ, Smith RC. Nielsen A, et al. J Gastroenterol Hepatol. 2005 Feb;20(2):256-63. doi: 10.1111/j.1440-1746.2004.03531.x. J Gastroenterol Hepatol. 2005. PMID: 15683429

5

Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.

Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC. Xue A, et al. Pancreas. 2008 Mar;36(2):160-7. doi: 10.1097/MPA.0b013e31815750f0. Pancreas. 2008. PMID: 18376307

6

Targeted alpha therapy approach to the management of pancreatic cancer.

Allen BJ, Rizvi SM, Qu CF, Smith RC. Allen BJ, et al. Cancers (Basel). 2011 Apr 1;3(2):1821-43. doi: 10.3390/cancers3021821. Cancers (Basel). 2011. PMID: 24212784 Free PMC article.

7

Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.

Aslani A, Gill AJ, Roach PJ, Allen BJ, Smith RC. Aslani A, et al. HPB (Oxford). 2010 Jun;12(5):325-33. doi: 10.1111/j.1477-2574.2010.00171.x. HPB (Oxford). 2010. PMID: 20590908 Free PMC article.

8

Changes in body composition during adjuvant chemotherapy for breast cancer.

Aslani A, Smith RC, Allen BJ, Levi JA. Aslani A, et al. Among authors: smith rc. Appl Radiat Isot. 1998 May-Jun;49(5-6):637-8. doi: 10.1016/s0969-8043(97)00199-1. Appl Radiat Isot. 1998. PMID: 9569564 No abstract available.

9

Role of body protein as a prognostic indicator in wasting disease.

Allen BJ, Pollock CA, Russell J, Oliver C, Smith R. Allen BJ, et al. Among authors: smith r. Asia Pac J Clin Nutr. 1995 Mar;4(1):31-3. Asia Pac J Clin Nutr. 1995. PMID: 24394245 Free article.

10

Determination of skeletal muscle and fat-free mass by nuclear and dual-energy x-ray absorptiometry methods in men and women aged 51-84 y (1-3).

Hansen RD, Raja C, Aslani A, Smith RC, Allen BJ. Hansen RD, et al. Among authors: smith rc. Am J Clin Nutr. 1999 Aug;70(2):228-33. doi: 10.1093/ajcn.70.2.228. Am J Clin Nutr. 1999. PMID: 10426699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,422 results

Search Page

Filters